20 June 2013
Keywords: pozen, coated, aspirin, tablet, shows, gi, damage
Article | 17 November 2008
US drugmaker Pozen says that its drug candidate PA32520 (enteric coated aspirin 325mg with immediate-release omeprazole 20mg) may cause less
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 November 2008
19 June 2013
© 2013 thepharmaletter.com